Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexey Bersenev

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Transfusion|April 21, 2017
CAR-T cell manufacturing: time to put it in gearAlexey Bersenev
Methods in Molecular Biology (Clifton, N.J.)|November 29, 2019
Place of Academic GMP Facilities in Modern Cell TherapyAlexey Bersenev, Andrew Fesnak
Regenerative Medicine|December 6, 2012
Convergence of gene and cell therapyAlexey Bersenev, Bruce L Levine
Cytotherapy|November 23, 2021
ISCT survey on hospital practices to support externally manufactured investigational cell-gene therapy productsAlexey Bersenev, Michael P Gustafson, Patrick J Hanley
Future Science OA|November 20, 2018
A dozen years of clinical trials performing advanced cell therapy with perinatal cellsFrances Verter, Pedro Silva Couto, Alexey Bersenev
Regenerative Medicine|November 16, 2017
The first decade of advanced cell therapy clinical trials using perinatal cells (2005-2015)Pedro S Couto, Alexey Bersenev, Frances Verter
The Journal of Clinical Investigation|July 12, 2008
Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2Alexey Bersenev, Chao Wu, Joanna Balcerek, et al.
Cytotherapy|November 10, 2021
Delivering externally manufactured cell and gene therapy products to patients: perspectives from the academic center experiencePatrick J Hanley, Alexey Bersenev, Michael P Gustafson
Regenerative Medicine|May 10, 2019
First decade of clinical trials and published studies with mesenchymal stromal cells from umbilical cord tissuePedro S Couto, Gocha Shatirishvili, Alexey Bersenev, et al.
Cytotherapy|June 5, 2026
Overcoming five main challenges to targeting hematologic malignanciesMegha Thakkar, Patrick J Hanley, Alexey Bersenev, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Transfusion|April 21, 2017
CAR-T cell manufacturing: time to put it in gearAlexey Bersenev
Methods in Molecular Biology (Clifton, N.J.)|November 29, 2019
Place of Academic GMP Facilities in Modern Cell TherapyAlexey Bersenev, Andrew Fesnak
Regenerative Medicine|December 6, 2012
Convergence of gene and cell therapyAlexey Bersenev, Bruce L Levine
Cytotherapy|November 23, 2021
ISCT survey on hospital practices to support externally manufactured investigational cell-gene therapy productsAlexey Bersenev, Michael P Gustafson, Patrick J Hanley
Future Science OA|November 20, 2018
A dozen years of clinical trials performing advanced cell therapy with perinatal cellsFrances Verter, Pedro Silva Couto, Alexey Bersenev
Regenerative Medicine|November 16, 2017
The first decade of advanced cell therapy clinical trials using perinatal cells (2005-2015)Pedro S Couto, Alexey Bersenev, Frances Verter
The Journal of Clinical Investigation|July 12, 2008
Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2Alexey Bersenev, Chao Wu, Joanna Balcerek, et al.
Cytotherapy|November 10, 2021
Delivering externally manufactured cell and gene therapy products to patients: perspectives from the academic center experiencePatrick J Hanley, Alexey Bersenev, Michael P Gustafson
Regenerative Medicine|May 10, 2019
First decade of clinical trials and published studies with mesenchymal stromal cells from umbilical cord tissuePedro S Couto, Gocha Shatirishvili, Alexey Bersenev, et al.
Cytotherapy|June 5, 2026
Overcoming five main challenges to targeting hematologic malignanciesMegha Thakkar, Patrick J Hanley, Alexey Bersenev, et al.
Pageof 3